Literature DB >> 23807483

Notch1 destabilizes the adherens junction complex through upregulation of the Snail family of E-cadherin repressors in non-small cell lung cancer.

Arum Kim1, Eun Young Kim, Eun Na Cho, Hyung Jung Kim, Se Kyu Kim, Joon Chang, Chul Min Ahn, Yoon Soo Chang.   

Abstract

One of the critical steps driving cancer cell migration and metastasis is the repression of cell adhesion molecules resulting in loss of cell‑to-cell adhesion. Although interactions between Notch1 and components of the adherens junction complex have been suggested, little is known concerning the consequence of their interactions. In this study, we investigated the interaction between the Notch1 and the E‑cadherin/β‑catenin complex, its effect on the expression of adherens junction complex components and its influence on non-small cell lung cancer (NSCLC) cell proliferation. With progression of lung neoplastic lesions in LSL K-ras G12D mice, the expression of E‑cadherin was inhibited whereas that of Notch1 was increased with frequent nuclear localization, suggesting an inverse relationship between E‑cadherin and Notch1 expression with tumor progression. Transduction of the human Notch1 intracellular domain (N1ICD) into NSCLC cells inhibited expression of E‑cadherin and β‑catenin and induced changes in the localization of adherens junction molecules. The loss of E‑cadherin was mediated through upregulation of the Snail family of transcription factors, Snail and Slug. Experiments in which siRNA against E-cadherin was introduced into NSCLC cells revealed that N1ICD decreased the expression of β‑catenin in an E‑cadherin‑independent manner, leading to inhibition of markers of Wnt/β‑catenin signaling activation. Despite inhibition of Wnt/β‑catenin signaling in the N1ICD‑transduced cells, cells transduced with N1ICD showed no difference in cell cycle progression when compared with that of the control vector-transduced cells. In conclusion, Notch1 inhibited the expression of E‑cadherin through upregulation of the Snail family of transcriptional factors, resulting in inhibition of expression of β‑catenin and destabilization of adherens junctions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23807483     DOI: 10.3892/or.2013.2565

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition.

Authors:  Lindsay R Saunders; David R McClay
Journal:  Development       Date:  2014-03-05       Impact factor: 6.868

Review 2.  Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.

Authors:  Takaaki Ito; Shinji Kudoh; Takaya Ichimura; Kosuke Fujino; Wael Ahmed Maher Abdo Hassan; Naoko Udaka
Journal:  Hum Cell       Date:  2016-10-26       Impact factor: 4.174

3.  Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion.

Authors:  Rui-Huan Gan; Hua Wei; Jing Xie; Dan-Ping Zheng; Er-Ling Luo; Xiao-Yu Huang; Jian Xie; Yong Zhao; Lin-Can Ding; Bo-Hua Su; Li-Song Lin; Da-Li Zheng; You-Guang Lu
Journal:  Cell Cycle       Date:  2017-12-21       Impact factor: 4.534

4.  Notch1 phenotype and clinical stage progression in non-small cell lung cancer.

Authors:  Dat Nguyen; Larry Rubinstein; Naoko Takebe; Lucio Miele; Joseph E Tomaszewski; Percy Ivy; James H Doroshow; Sherry X Yang
Journal:  J Hematol Oncol       Date:  2015-02-06       Impact factor: 17.388

5.  ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer.

Authors:  Eun Young Kim; Ji Ye Jung; Arum Kim; Yoon Soo Chang; Se Kyu Kim
Journal:  Neoplasia       Date:  2017-03-17       Impact factor: 5.715

6.  A novel Notch1 missense mutation (C1133Y) in the Abruptex domain exhibits enhanced proliferation and invasion in oral squamous cell carcinoma.

Authors:  Yang Zheng; Zhao Wang; Xu Ding; Wei Zhang; Gang Li; Laikui Liu; Heming Wu; Wenyi Gu; Yunong Wu; Xiaomeng Song
Journal:  Cancer Cell Int       Date:  2018-01-08       Impact factor: 5.722

Review 7.  Roles of NOTCH1 as a Therapeutic Target and a Biomarker for Lung Cancer: Controversies and Perspectives.

Authors:  Lixia Guo; Ting Zhang; Ying Xiong; Yanan Yang
Journal:  Dis Markers       Date:  2015-09-27       Impact factor: 3.434

8.  Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells.

Authors:  Eun Young Kim; Arum Kim; Se Kyu Kim; Hyung Jung Kim; Joon Chang; Chul Min Ahn; Yoon Soo Chang
Journal:  Respir Res       Date:  2014-02-26

9.  Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma.

Authors:  Jiayuan Huang; Haizhu Song; Biao Liu; Bo Yu; Rui Wang; Longbang Chen
Journal:  J Exp Clin Cancer Res       Date:  2013-10-27

10.  2,3,5,4‑tetrahydroxy diphenylethylene‑2‑O‑glucoside inhibits the adhesion and invasion of A549 human lung cancer cells.

Authors:  Ming Xu; Cong Wang; Minglin Zhu; Xianguo Wang; Li Zhang; Jinping Zhao
Journal:  Mol Med Rep       Date:  2017-10-02       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.